Results 11 to 20 of about 25,921 (246)
How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias [PDF]
Pharmacoepidemiology and Drug Safety, 2020 Several pharmacoepidemiology networks have been developed over the past decade that use a distributed approach, implementing the same analysis at multiple data sites, to preserve privacy and minimize data sharing.
Robert W Platt +2 more
exaly +3 more sources
PHARMACOEPIDEMIOLOGY IN THE ASSORTMENT POLICY-PRODUCER OF DRUGS
Фармация и фармакология (Пятигорск), 2015 RETRACTED ARTICLEThe analysis of the range of the medicines presented by the pharmaceutical company «Servier » in the Russian market, applied is carried out at treatment of a wide range of diseases.
V. Y. Krasnov
doaj +2 more sources
British journal of clinical pharmacology, 2012 Current concerns over the safety of medicines once they have been marketed mean that pharmacoepidemiology is of increasing importance. There are three main areas in which further research is needed.
Evans, Stephen JW
core +6 more sources
Preregistration of high‐quality protocols in pharmacoepidemiology research [PDF]
JCPP AdvancesPharmacoepidemiology studies are an important complement to Randomized Clinical trials, but such studies face several challenges, such as confounding and selective reporting.
Henrik Larsson +2 more
doaj +2 more sources
PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE
Фармакоэкономика, 2015 pharmacoepidemiology is a well recognized throughout the world scientific discipline studying the use of and the effects of drugs in the whole population or in large groups of people in order to improve efficacy and safety of pharmacotherapy. Despite its
S. A. Rachina +2 more
doaj +1 more source
ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY
Фармакоэкономика, 2015 : pharmacoepidemiology has recently evolved into a self-dependent post-marketing disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from epidemiology.
T. L. Galankin, A. S. Kolbin
doaj +1 more source
Clinical Therapeutics, 2019 At the time of their marketing authorization, the effects of drugs and especially their efficacy have been mostly studied in randomized controlled clinical trials (RCT), comparing them to placebo or to existing drugs. However, RCT are by nature limited in their extent, and the often stringent inclusion and exclusion criteria destined to provide for ...
Nicholas, Moore +2 more
+7 more sources
Pharmacoepidemiology: An Overview
Journal of Clinical Medicine, 2023 The aims of this review are to provide a comprehensive overview of the definition and scope of pharmacoepidemiology, to summarize the study designs and methodologies used in the field, to discuss the future trends in the field and new methodologies to address bias and confounding, and finally to give some recommendations to clinicians interested in ...
Mònica Sabaté, Eva Montané
openaire +6 more sources
JID Innovations, 2023 The U.S. Food and Drug Administration and clinical guidelines use evidence from pharmacoepidemiology studies to inform prescribing decisions and fill evidence gaps left by randomized controlled trials (RCTs).
Sebastian Schneeweiss +1 more
doaj +1 more source
Use of Hand Sanitizers in COVID-19 Prevention: A Comprehensive Overview
Pharmacoepidemiology, 2023 The pandemic outbreak of Coronavirus disease 2019 (COVID-19) has drastically changed the picture of global healthcare. With the rapid emergence of novel variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that rendered the currently ...
Suneetha Vuppu +2 more
doaj +1 more source